
|Articles|November 30, 2012
Supplements and Featured Publications
- New Approaches to Measuring Value in Oncology Therapy
- Volume 18
- Issue 11 Suppl
Appendix B -- Value of Survival Gains in Chronic Myeloid Leukemia
Advertisement
Articles in this issue
almost 13 years ago
eAppendix -- New Approaches to Measuring Value in Oncology Therapyalmost 13 years ago
Appendix A -- Value of Survival Gains in Chronic Myeloid Leukemiaalmost 13 years ago
Participating Faculty: New Approaches to Measuring Value in Oncology Therapyalmost 13 years ago
Dynamic Cost-Effectiveness of Oncology Drugsalmost 13 years ago
Value of Survival Gains in Chronic Myeloid LeukemiaNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Value-Based Care Interventions and Management of CKD Progression
5